These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5208076)

  • 21. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 22. [The importance of unusual isoimmunizations in the prophylaxis of hemolytic disease of the newborn].
    Joó-Szabados T; Neubauer G; Székessy V; Wohlmuth G
    Acta Paediatr Acad Sci Hung; 1970; 11(2):111-4. PubMed ID: 5504582
    [No Abstract]   [Full Text] [Related]  

  • 23. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 24. The prevention of haemolytic disease of the newborn.
    Mellon DE
    Ir J Med Sci; 1967 Jun; 6(498):276-80. PubMed ID: 6069026
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemolytic disease of the newborn and glucocorticoid treatment].
    Hüter KA; Haering M; Gerteis W
    Geburtshilfe Frauenheilkd; 1966 Oct; 26(10):1352-9. PubMed ID: 5923679
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemolytic disease of the newborn: management in pregnancy.
    Morton BS
    N S Med Bull; 1965 Oct; 44(10):255-6. PubMed ID: 5212985
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemolytic diseases of the newborn and their prevention].
    SEMENOVA EI
    Feldsher Akush; 1954 Apr; 4():26-9. PubMed ID: 13183152
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience in prenatal detection and control of hemolytic disease of newborn].
    Schmidt D; Widmaier G
    Dtsch Gesundheitsw; 1970 Mar; 25(9):394-8. PubMed ID: 5483682
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prenatal immunological research on hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):563-5. PubMed ID: 6788016
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomized controlled trial of plasma exchange for hemolytic disease due to anti-D.
    Rock GA
    Can Med Assoc J; 1984 Nov; 131(9):1022. PubMed ID: 6388778
    [No Abstract]   [Full Text] [Related]  

  • 31. Rhesus haemolytic disease; an approach to prevention.
    Finn R
    Nurs Times; 1965 Sep; 61(38):1267-9. PubMed ID: 5889760
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current insights regarding the prevention of hemolytic diseases in newborn infants].
    Dudok de Wit C
    Ned Tijdschr Geneeskd; 1966 Oct; 110(44):1952-4. PubMed ID: 6009443
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunologically induced hemolytic anemias].
    Hitzig WH; Lo SS
    Ther Umsch; 1968 Aug; 25(8):426-32. PubMed ID: 5729306
    [No Abstract]   [Full Text] [Related]  

  • 35. Current concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Mt Sinai J Med; 1980; 47(5):454-60. PubMed ID: 6969353
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn infant. Occurrence and therapeutic results].
    Aichner R
    Wien Med Wochenschr; 1970 Jul; 120(27):494-7. PubMed ID: 5314307
    [No Abstract]   [Full Text] [Related]  

  • 37. The prevention of Rhesus haemolytic disease: the present position.
    Clarke C
    Haematologia (Budap); 1982 Dec; 15(4):419-21. PubMed ID: 7186480
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of rhesus haemolytic disease in Finland.
    Eklund J
    Haematologia (Budap); 1982 Dec; 15(4):423-6. PubMed ID: 6821166
    [No Abstract]   [Full Text] [Related]  

  • 39. [Perinatal hemolytic disease. Part 2: Prevention and management].
    Hohlfeld P; Wirthner D; Tissot JD
    J Gynecol Obstet Biol Reprod (Paris); 1998 Apr; 27(3):265-76. PubMed ID: 9648004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.